𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The presence of anti-carcinoembryonic antigen (CEA) antibodies in the sera of patients with gastrointestinal malignancies

✍ Scribed by Manoussos M. Konstadoulakis; Konstantinos N. Syrigos; Costas Albanopoulos; George Mayers; Basil Golematis

Publisher
Springer
Year
1994
Tongue
English
Weight
473 KB
Volume
14
Category
Article
ISSN
0271-9142

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Absence of circulating antibodies to car
Absence of circulating antibodies to carcinoembryonic antigen in patients with gastrointestinal malignancies
✍ P. Lo Gerfo; F. P. Herter; S. J. Bennett πŸ“‚ Article πŸ“… 1972 πŸ› John Wiley and Sons 🌐 French βš– 322 KB

## Abstract The zirconyl phosphate gel assay (Z‐gel) was used to assay sera of 265 patients for humoral activity against carcinoembryonic antigen (CEA). Included in the patients tested were 110 with non‐metastatic colon carcinoma, 122 with other gastrointestinal, breast and pulmonary neoplasms, 20

Prevalence of antibodies to hepatitis a
Prevalence of antibodies to hepatitis a antigen in sera from patients with hematological malignancies
✍ E. Sandra McFarlane; Juan A. Embil πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 268 KB

## Abstract The prevalence of antibodies to hepatitis A (anti‐HA) was investigated in patients attending a clinic for hematological malignancies. Patients were divided into three age groups; the number with antibodies in each group was recorded. Of the 130 patients studied, 44% of those aged 4–26,

Induction of carcinoembryonic antigen (c
Induction of carcinoembryonic antigen (cea)-specific cytotoxic t-lymphocyte responses In vitro using autologous dendritic cells loaded with cea peptide or cea rna in patients with metastatic malignancies expressing cea
✍ Smita K. Nair; Shelley Hull; Doris Coleman; Eli Gilboa; H. Kim Lyerly; Michael A πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 107 KB πŸ‘ 2 views

The application of dendritic cells (DC) to the active immunotherapy of cancer currently relies on the generation of potent DC capable of presenting tumor antigens such as carcinoembryonic antigen (CEA). It is unknown whether the T cells of patients with advanced malignancies can be reliably stimulat